Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1

Journal of Neuroscience

Volumn 30, Issue 10, 2010, Pages 3831-3838

  Öz, Gülin ^a   Nelson, Christopher D ^a   Koski, Dee M ^a   Henry, Pierre Gilles ^a   Marjańska, Małgorzata ^a   Deelchand, Dinesh K ^a   Shanley, Ryan ^b   Eberly, Lynn E ^b   Orr, Harry T ^a   Clark, H Brent ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; INOSITOL; N ACETYLASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CEREBELLAR ATAXIA; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE COURSE; EARLY INTERVENTION; FEMALE; HISTOPATHOLOGY; MALE; MOUSE; NERVE DEGENERATION; NEUROCHEMISTRY; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; REPETITIVE SEQUENCES, AMINO ACID; SPINOCEREBELLAR ATAXIAS;

EID: 77949371220     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5612-09.2010     Document Type: Article

References (39)

1. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB (1996) Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7:1397-1400.
2. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289 -298.
3. Burright EN, Clark HB, Servadio A, Matilla T, Feddersen RM, Yunis WS, Duvick LA, Zoghbi HY, Orr HT (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82:937-948.
4. Clark HB, Burright EN, Yunis WS, Larson S, Wilcox C, Hartman B, Matilla A, Zoghbi HY, Orr HT (1997) Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci 17:7385-7395.
5. Clark JB (1998) N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20:271-276.
6. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Condé F, Bloch G, Hantraye P (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 20:789 -799.
7. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, Marie C (2001) N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 77:408-415.
8. Ernst T, Kreis R, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson 102:1- 8.
9. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101-106.
10. Fisher SK, Novak JE, AgranoffBW (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82:736 -754.
11. Garwood M, DelaBarre L (2001) The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 153:155-177.
12. Govindaraju V, Young K, Maudsley AA (2000) ProtonNMRchemical shifts and coupling constants for brain metabolites. NMR Biomed 13:129 -153.
13. Gruetter R, Tkáč I (2000) Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med 43:319 -323.
14. Hennig J, Nauerth A, Friedburg H (1986) RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 3:823- 833.
15. Henry PG, Marjanska M, Walls JD, Valette J, Gruetter R, Ugurbil K (2006) Proton-observed carbon-edited NMR spectroscopy in strongly coupled second-order spin systems. Magn Reson Med 55:250 -257.
16. Holm S (1979) A simple sequentially rejective Bonferroni test procedure. Scand J Statist 6:65-70.
17. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1H MR spectroscopy in common dementias. Neurology 63:1393-1398.
18. Klockgether T, Dichgans J (1997) The genetic basis of hereditary ataxia. Prog Brain Res 114:569 -576.
19. Kofke WA, Hawkins RA, Davis DW, Biebuyck JF (1987) Comparison of the effects of volatile anesthetics on brain glucose metabolism in rats. Anesthesiology 66:810-813.
20. Lin X, Antalffy B, Kang D, Orr HT, Zoghbi HY (2000) Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci 3:157-163.
21. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR Jr, Ugurbil K, Garwood M (2005) Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 102: 11906 -11910.
22. Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LP, Zoghbi HY (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4:221-226.
23. Ottersen OP (1988) Quantitative assessment of taurine-like immunoreactivity in different cell types and processes in rat cerebellum: an electronmicroscopic study based on a postembedding immunogold labelling procedure. Anat Embryol (Berl) 178:407- 421.
24. Öz G, Tkáč I, Charnas LR, Choi IY, Bjoraker KJ, Shapiro EG, Gruetter R (2005) Assessment of adrenoleukodystrophy lesions by high fieldMRSin non-sedated pediatric patients. Neurology 64:434-441.
25. Öz G, Hutter D, Tkáč I, Clark HB, GrossMD,Jiang H, Eberly LE, Bushara KO, Gomez CM (2010) Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord. Advance online publication. Retrieved February 26, 2010. doi: 10.1002/mds.23067.
26. Pouwels PJ, Kruse B, Korenke GC, Mao X, Hanefeld FA, Frahm J (1998) Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 29:254 -264.
27. ProvencherSW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672- 679.
28. Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, et al. (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717-1720.
29. Serra HG, Byam CE, Lande JD, Tousey SK, Zoghbi HY, Orr HT (2004) Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum Mol Genet 13:2535-2543.
30. Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT (2006) RORα-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 127:697-708.
31. Storm-Mathisen J, Danbolt NC, Rothe F, Torp R, Zhang N, Aas JE, Kanner BI, Langmoen I, Ottersen OP (1992) Ultrastructural immunocytochemical observations on the localization, metabolism and transport of glutamate in normal and ischemic brain tissue. Prog Brain Res 94:225-241.
32. Tkáč I (2008) Refinement of simulated basis set for LCModel analysis. Proceedings of the 16th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, p 1624. St. Louis: Mira Digital.
33. Tkáč I, Starcuk Z, Choi I-Y, Gruetter R (1999) In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 41:649-656.
34. Tkáč I, Henry PG, Andersen P, Keene CD, Low WC, Gruetter R (2004) Highly resolved in vivo 1HNMRspectroscopy of the mouse brain at 9.4 T. Magn Reson Med 52:478-484.
35. Valette J, Guillermier M, Besret L, Hantraye P, Bloch G, Lebon V (2007) Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by 1H nuclear magnetic resonance spectroscopy of the monkey brain. J Cereb Blood Flow Metab 27:588 -596.
36. Vrenken H, Barkhof F, Uitdehaag BM, Castelijns JA, Polman CH, Pouwels PJ (2005) MR spectroscopic evidence for glial increase but not for neuroaxonal damage in MS normal-appearing white matter. Magn Reson Med 53:256 -266.
37. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, Paulson HL, Yang L, Kotin RM, Davidson BL (2004) RNAi suppresses polyglutamineinduced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10:816-820.
38. Zoghbi HY, Orr HT (1995) Spinocerebellar ataxia type 1. Semin Cell Biol 6:29-35.
39. Zu T, Duvick LA, Kaytor MD, Berlinger MS, Zoghbi HY, Clark HB, Orr HT (2004) Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci 24:8853- 8861.